Dr. Reddy's Laboratories Limited
Price Action
Technical Summary
WEAKENINGDr. Reddy's Laboratories Limited is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 63), indicating performance broadly in line with the market. Earnings contraction of 86% provides fundamental context to the price action. However, with RSI at 79, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $13.69 | +8.55% | ABOVE |
| 50 SMA | $13.54 | +9.77% | ABOVE |
| 100 SMA | $13.75 | +8.10% | ABOVE |
| 150 SMA | $13.76 | +8.01% | ABOVE |
| 200 SMA | $13.86 | +7.21% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RDY in an uptrend right now?
RDY has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is RDY overbought or oversold?
RDY's RSI (14) is 79. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is RDY outperforming the market?
RDY has a Relative Strength (RS) Rating of 63 out of 99. RDY is performing about average compared to the market.
Where is RDY in its 52-week range?
RDY is trading at $14.86, which is 95% of its 52-week high ($15.67) and 77% above its 52-week low ($12.19).
How volatile is RDY?
RDY has a Beta of 0.30 and 52-week volatility of 24%. It's less volatile than the S&P 500 - generally more stable.